These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21546231)

  • 41. Resolvins: Current understanding and future potential in the control of inflammation.
    Bannenberg GL
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):644-58. PubMed ID: 19736623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury.
    Rice TW; Wheeler AP; Thompson BT; deBoisblanc BP; Steingrub J; Rock P;
    JAMA; 2011 Oct; 306(14):1574-81. PubMed ID: 21976613
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of resolvins in the resolution of acute inflammation.
    Qu Q; Xuan W; Fan GH
    Cell Biol Int; 2015 Jan; 39(1):3-22. PubMed ID: 25052386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmaconutrition: acute fatty acid modulation of circulating cytokines in elderly patients in the ICU.
    Barros KV; Cassulino AP; Schalch L; Della Valle Munhoz E; Manetta JA; Calder PC; Flor Silveira VL
    JPEN J Parenter Enteral Nutr; 2014 May; 38(4):467-74. PubMed ID: 23471207
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Resolvins and protectins in the termination program of acute inflammation.
    Ariel A; Serhan CN
    Trends Immunol; 2007 Apr; 28(4):176-83. PubMed ID: 17337246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. n-3 Fatty acid supplementation and proresolving mediators of inflammation.
    Barden AE; Mas E; Mori TA
    Curr Opin Lipidol; 2016 Feb; 27(1):26-32. PubMed ID: 26655290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Essential fatty acids and lipid mediators. Endocannabinoids].
    Caramia G
    Pediatr Med Chir; 2012; 34(2):65-72. PubMed ID: 22730630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients.
    Calder PC
    Braz J Med Biol Res; 2003 Apr; 36(4):433-46. PubMed ID: 12700820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nutritional interventions to prevent and treat osteoarthritis. Part I: focus on fatty acids and macronutrients.
    Lopez HL
    PM R; 2012 May; 4(5 Suppl):S145-54. PubMed ID: 22632694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lipids in the nutritional support of the critically ill patients.
    Hasselmann M; Reimund JM
    Curr Opin Crit Care; 2004 Dec; 10(6):449-55. PubMed ID: 15616385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
    Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
    Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nutrition intervention: a strategy against systemic inflammatory syndrome.
    Oz HS; Chen TS; Neuman M
    JPEN J Parenter Enteral Nutr; 2009; 33(4):380-9. PubMed ID: 19380752
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases.
    Chen Y; Wang J; Nie R; Zhou S
    Med Hypotheses; 2008 Aug; 71(2):237-40. PubMed ID: 18448265
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implications for eicosapentaenoic acid- and docosahexaenoic acid-derived resolvins as therapeutics for arthritis.
    Souza PR; Norling LV
    Eur J Pharmacol; 2016 Aug; 785():165-173. PubMed ID: 26165764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis.
    Lubrano V; Ndreu R; Balzan S
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675152
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Importance of lipids in the nutritional treatment of inflammatory diseases.
    Mesa García MD; Aguilera García CM; Gil Hernández A
    Nutr Hosp; 2006 May; 21 Suppl 2():28-41, 30-43. PubMed ID: 16771071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lipid Mediators in Inflammation.
    Bennett M; Gilroy DW
    Microbiol Spectr; 2016 Nov; 4(6):. PubMed ID: 27837747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rationale and use of n-3 fatty acids in artificial nutrition.
    Calder PC
    Proc Nutr Soc; 2010 Nov; 69(4):565-73. PubMed ID: 20441676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Resolvins as new fascinating drug candidates for inflammatory diseases.
    Lee CH
    Arch Pharm Res; 2012 Jan; 35(1):3-7. PubMed ID: 22297737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune-modulating interventions in critically ill septic patients: pharmacological options.
    Toft P; Tønnesen E
    Expert Rev Clin Pharmacol; 2011 Jul; 4(4):491-501. PubMed ID: 22114858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.